Modified Pectoral Nerve Block Versus Serratus Plane Block
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
In PECSII or modified PECSI block, local anesthetic (LA) is injected between pectoralis major muscle (PMm) and pectoralis minor muscle (Pmm) to block lateral and medial pectoral nerves and between pectoralis minor muscle (Pmm) and serratus anterior muscle in the anterior axillary line to block the intercostal nerves II-VI (Blanco et al., 2012). In Serratus anterior plane block (SAPB) local anesthetic (LA) is injected above the serratus muscle (between latissmus dorsi muscle and serratus muscle) or below the serratus muscle (between serratus muscle and 4th rib) in the mid-axillary line to block the intercostal nerves II-VI and spares the pectoral nerves (Blanco et al., 2013).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started May 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2021
CompletedFirst Posted
Study publicly available on registry
May 20, 2021
CompletedStudy Start
First participant enrolled
May 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2023
CompletedMay 20, 2021
May 1, 2021
2.1 years
April 24, 2021
May 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
assess analgesic effect of nerve block
We assess the analgesic effect by VAS ( visual analogue scale )
24hour post-operative
Study Arms (2)
Group A: (30 patients)
ACTIVE COMPARATORmodified pectoral nerve block will be done.
Group B: (30 patients)
ACTIVE COMPARATORserratus plane block will be done.
Interventions
In group A patients, an ultrasound guided modified pectoral nerve block will be performed Under sterile conditions, US-guided PECSII block will be on the same side of surgery . The 6-13 MHz linear probe will be put transversely in the ipsilateral clavipectoral triangle - between the clavicle medially and above and the shoulder joint laterally. the needle will be advanced in an in-plane technique targeting the space in which the artery is located. Afterward, 10 mL of bupivacaine, 0.25%, will be injected. the needle will be advanced in-plane targeting the plane between the pectoralis minor muscle and serratus. Two mL of saline 0.9% will be injected; then, 10 mL of bupivacaine 0.25% will be injected. Group B: In SAPB Group, a US-guided serratus block will be done The ribs will be then counted, and when the 4th rib will be identified, the high-frequency probe will be put over it, in the mid-axillary line in a sagittal plane.
Eligibility Criteria
You may qualify if:
- Breast cancer surgery.
- Age 20 to 60 years.
- Female patients.
- At least 24 hours post-operative hospital admission.
- ASA (American society of anesthesiologist) physical status classification system І to Ш.
You may not qualify if:
- Morbid obesity (body mass index \> 40).
- Impossibility of anatomical structures identification by ultrasound in a satisfactory way (there can be no distinction in the interfacial plan between serratus and pectoral muscle).
- Opioids treatment before surgery or substance abuse.
- Sepsis and/or infection at the puncture site.
- Hemostasis disorders.
- Allergy to any of the drugs used in the study.
- Less than 24 hours postoperative hospital admission.
- Inability to communicate with the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mohammed hussein, lecturer
Sohag University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
April 24, 2021
First Posted
May 20, 2021
Study Start
May 20, 2021
Primary Completion
June 20, 2023
Study Completion
August 20, 2023
Last Updated
May 20, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share